Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Roger’s last purchase

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Aug 22, 2022 2:06pm

224 Views

Post# 34911925

RE:RE:RE:RE:Roger’s last purchase

Even if no "quarterly report", IMO there will likely be an update in the MD&A that accompanys their Q2 financials expected on or before Aug.31

FGPstock wrote:
Legit, is there an actual reference to some sort of news, update, report at the end of aug? i thought they did away w the quarterly report

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023